Skip to content

QT Imaging Holdings, Inc. QTI Cash and cash equivalents, end of period

Cash and cash equivalents, end of period at other companies

BioSig Technologies, Inc. logo
BioSig Technologies, Inc.STEX

Other financials

Income statement

See full
Revenue$6.5M+133%
Gross profit$2.7M+47.5%
Operating income-$2.3M-125%
Net income-$3.4M+69.4%
EPS (diluted)-$0.25+79.3%

Balance sheet

See full
Cash & equivalents$6.9M+131%
Total debt$10.6M-4.4%
Total equity$3.8M+119%
Total assets$22.0M+103%

Cash flow

See full
Operating cash flow-$3.7M-3.3%
CapEx$17.0K
Free cash flow-$3.7M-3.8%

Valuation

See full
Market cap$53.9M-18.4%
Enterprise value$57.65M-4.7%
P/S2.4×-1.1×

Profitability

See full
Gross margin41.7%-16.8pp
Operating margin-25.4%-11.2pp
Net margin-58.9%-26.4pp
FCF margin-40.7%

Returns & leverage

See full
Return on equity162.8%
Debt / equity2.8×
Current ratio2.5×+0.6×

Where this comes from

Reported directly by QT Imaging Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: QT Imaging Holdings, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about QT Imaging Holdings, Inc.'s cash and cash equivalents, end of period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QT Imaging Holdings, Inc.'s cash and cash equivalents, end of period?
QT Imaging Holdings, Inc. (QTI) reported cash and cash equivalents, end of period of $6.95M in Q1 2026.
How has QT Imaging Holdings, Inc.'s cash and cash equivalents, end of period changed year-over-year?
QT Imaging Holdings, Inc.'s cash and cash equivalents, end of period increased by 131.1% year-over-year, from $3.01M to $6.95M.
What is the long-term trend for QT Imaging Holdings, Inc.'s cash and cash equivalents, end of period?
Over 4 years (2021 to 2025), QT Imaging Holdings, Inc.'s cash and cash equivalents, end of period has grown at a 123.2% compound annual growth rate (CAGR), from $421.55K to $10.46M.